BLT Ø2.9MM SC, SLACTIVE® 10MM, RXD, LOXI
Report
- Report Number
- 1222315-2018-00614
- Event Type
- Injury
- Date Received
- October 23, 2018
- Date of Event
- September 19, 2018
- Report Date
- October 19, 2018
- Manufacturer
- STRAUMANN USA, LLC
- Product Code
- DZE
- UDI-DI
- 07630031728005
- PMA / PMN Number
- K162890
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- DENTIST
Narratives
THE BATCH NUMBER COULD BE VERIFIED. OUR MANUFACTURING Q-SYSTEM ASSURES THAT PRODUCTION AND PROCESS CONTROLS ARE IN PLACE TO ENSURE THAT BATCHES CONFIRM TO THE APPLICABLE SPECIFICATIONS BEFORE THEY ARE DISTRIBUTED. THE LOSS OF AN ENDOSSEOUS DENTAL IMPLANT AFTER SUCCESSFUL OSSEOINTEGRATION AND RESTORATION IS A KNOWN INHERENT RISK OF THE PROCEDURE. IMPLANTS MAY HAVE TO BE REMOVED IN CASE ONE OR MORE OF THE IMPLANT SUCCESS CRITERIA ARE NOT MET. IMPLANT SUCCESS CRITERIA ACCORDING TO BUSER ET AL. (1991) ARE: ABSENCE OF PERSISTENT SUBJECTIVE COMPLAINTS SUCH AS PAIN, FOREIGN BODY SENSATION AND /OR DISESTHESIA; ABSENCE OF A RECURRENT PERI-IMPLANT INFECTION WITH SUPPURATION; ABSENCE OF IMPLANT MOBILITY; ABSENCE OF A CONTINUOUS RADIOLUCENCY AROUND THE IMPLANT. THE MANUFACTURER'S TREND ANALYSIS CONFIRMS THAT THE REPORTED LATE FAILURE RATE ASSOCIATED WITH ITS DENTAL IMPLANTS IS BELOW THE EXPECTED FAILURE RATE FOR THIS TREATMENT AS PUBLISHED IN THE SCIENTIFIC LITERATURE.
THE CLINICIAN REPORTED THAT 14 MONTHS AFTER THE IMPLANT WAS PLACED IN THE PATIENT'S MOUTH THE IMPLANT FAILED "GTO" OSSEOINTEGRATE. IT WAS REPORTED THAT THE PATIENT HAD TYPE III BONE QUALITY, GOOD HYGIENE AROUND THE IMPLANT, PAIN AND IMPLANT MOBILITY AT THE TIME OF THE EVENT. THE PRODUCT WAS RETURNED TO THE MANUFACTURER FOR INVESTIGATION. THERE WERE NO REPORTED POST-OPERATIVE COMPLICATIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 837436 | BLT Ø2.9MM SC, SLACTIVE® 10MM, RXD, LOXI | ENDOSSEOUS DENTAL IMPLANT | DZE | STRAUMANN USA, LLC | NA | NF965 | 07630031728005 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |